Opal Oncology Overview

  • Founded
  • 2012
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $1.3M
Latest Deal Amount
  • Investors
  • 3

Opal Oncology General Information


Developer of brain cancer therapies created to provide treatment for incurable brain cancer. The company's therapies are primarily focused on killing a range of brain cancer cell lines over current GBM (GlioblastomaMultiforme) treatments holding out the possibility of increasing life expectancy, enabling healthcare sectors to deliver proper treatment for brain cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 23, Cambridge Science Park
  • Cambridge CB4 0EY
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Opal Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 08-Sep-2015 $1.3M 00.00 00.000 Completed Generating Revenue
1. Grant 02-Aug-2012 Completed Startup
To view Opal Oncology’s complete valuation and funding history, request access »

Opal Oncology Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 000.00 000.00 00 000.00 00.00
Ordinary 000 000.00 000.00 00 000.00 0.000
To view Opal Oncology’s complete cap table history, request access »

Opal Oncology Patents

Opal Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201805386-D0 Pharmaeutical compounds Ceased 31-Mar-2018 0000000000

Opal Oncology Executive Team (2)

Name Title Board Seat Contact Info
Sunil Shah Chief Executive Officer and Licensing
Andrew Morley Chief Scientific Officer
To view Opal Oncology’s complete executive team members history, request access »

Opal Oncology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
O2h Ventures Venture Capital Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Medical Research Council Corporation 000 0000 000000 0
To view Opal Oncology’s complete investors history, request access »